Lexicon Pharmaceuticals reported $441M in Market Capitalization this September of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbott ABT:US USD 191.43B 21.98B
Acadia Pharmaceuticals ACAD:US USD 2.65B 373M
Acorda Therapeutics ACOR:US USD 7M 1000K
Agios Pharmaceuticals AGIO:US USD 1.55B 335M
Akebia Therapeutics AKBA:US USD 58M 7M
Alnylam Pharmaceuticals ALNY:US USD 24.62B 6.97B
AstraZeneca AZN:LN USD 154.08B 13.26B
Biomarin Pharmaceutical BMRN:US USD 15.72B 392M
Bluebird Bio BLUE:US USD 488M 192M
Clovis Oncology CLVS:US USD 172M 87M
Coherus Biosciences CHRS:US USD 747M 186M
Eli Lilly And LLY:US USD 307.24B 831M
Esperion Therapeutics ESPR:US USD 446M 45M
Halozyme Therapeutics HALO:US USD 5.45B 622M
Illumina ILMN:US USD 29.97B 1.01B
Insmed INSM:US USD 2.62B 258M
Intercept Pharmaceuticals ICPT:US USD 574M 164M
Ironwood Pharmaceuticals IRWD:US USD 1.59B 186M
Johnson & Johnson JNJ:US USD 461.85B 32.35B
Lexicon Pharmaceuticals LXRX:US USD 441M 163M
Macrogenics MGNX:US USD 213M 32M
Mannkind MNKD:US USD 813M 149M
Merk MRK:US USD 218.17B 12.39B
Moderna Inc MRNA:US USD 46.26B 10.56B
Novartis NOVN:VX USD 181.55B 12.79B
Ptc Therapeutics PTCT:US USD 3.61B 742M
Puma Biotechnology PBYI:US USD 108M 20M
Regulus Therapeutics RGLS:US USD 25M 5M
Sarepta Therapeutics SRPT:US USD 9.68B 3.12B
Thermo Fisher Scientific TMO:US USD 198.71B 13.96B
Ultragenyx Pharmaceutical RARE:US USD 2.9B 1.27B
United Therapeutics UTHR:US USD 9.53B 1.14B
Vanda Pharmaceuticals VNDA:US USD 559M 57M